Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Primary brain tumors cumulatively represent the most common solid tumors of childhood and are the leading cause of cancer related death in this age group. Traditionally, molecular findings and histological analyses from biopsies of resected tumor tissue have been used for diagnosis and classification of these diseases. However, there is a dearth of useful biomarkers that have been validated and clinically implemented for pediatric brain tumors. Notably, diseases of the central nervous system (CNS) can be assayed through analysis of cerebrospinal fluid (CSF) and as such, CSF represents an appropriate medium to obtain liquid biopsies that can be informative for diagnosis, disease classification and risk stratification. Proteomic profiling of pediatric CNS malignancies has identified putative protein markers of disease, yet few effective biomarkers have been clinically validated or implemented. Advances in protein quantification techniques have made it possible to conduct such investigations rapidly and accurately through proteome-wide analyses. This review summarizes the current literature on proteomics in pediatric neuro-oncology and discusses the implications for clinical applications of proteomics research. We also outline strategies for translating effective CSF proteomic studies into clinical applications to optimize the care of this patient population.
MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.|Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.|The Hospital for Sick Children, Toronto, ON, Canada.
Nardin
N
Samuel
The Hospital for Sick Children, Toronto, ON, Canada.
Marc
M
Remke
The Hospital for Sick Children, Toronto, ON, Canada.|Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
James T
JT
Rutka
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Brian
B
Raught
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. david.malkin@sickkids.ca.|The Hospital for Sick Children, Toronto, ON, Canada. david.malkin@sickkids.ca.|Department of Pediatrics, University of Toronto, Toronto, ON, Canada. david.malkin@sickkids.ca.
David
D
Malkin
D000818:Animals; D015415:Biomarkers / Q000134:cerebrospinal fluid; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid*; D002648:Child; D006801:Humans; D040901:Proteomics / Q000379:methods*
D015415:Biomarkers